← Browse by Condition
Medical Condition

diffuse cutaneous systemic sclerosis

Total Trials
2
Recruiting Now
2
Trial Phases
Phase 3, Phase 2

ClinicalMetric tracks all active clinical trials for diffuse cutaneous systemic sclerosis sourced from ClinicalTrials.gov. Each listing includes the NCT identifier, current recruitment status, phase, primary endpoints, sponsor, estimated enrollment, and participating countries — updated daily as new studies open and status changes.

  • Recruiting trials currently enrolling participants, with eligibility criteria and age requirements
  • Phase 1–4 studies from early safety trials to post-marketing surveillance
  • NIH, pharmaceutical sponsor, and academic medical center studies worldwide
  • AI-powered plain-language summary available for every trial listing
Trial Phases
Phase 2
1
Phase 3
1
Top Sponsors
Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh 1 trial
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 1 trial

Recruiting Clinical Trials

NCT06936215 Phase 3
Recruiting

Safety and Efficacy of Baricitinib on Skin Tightening in Diffuse Cutaneous Systemic Sclerosis: A Comparative Study With Methotrexate

Enrollment
24 pts
Location
Bangladesh
Sponsor
Bangabandhu Sheikh Mujib Medic...
View Trial →
NCT05149768 Phase 2
Recruiting

Open Label Extension Study of Brentuximab Vedotin in Early dcSSc

Enrollment
11 pts
Location
Canada
Sponsor
London Health Sciences Centre ...
View Trial →
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology